Interleukin-1 Receptor Antagonist [EPC]

8624 reported adverse events

Drugs of this class: ANAKINRA

These side effects are most commonly reported by patients taking drugs of the Interleukin-1 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 2430
1 OFF LABEL USE 1958
2 RHEUMATOID ARTHRITIS 1006
3 JOINT SWELLING 900
4 PAIN 869
5 DRUG INTOLERANCE 748
6 CONDITION AGGRAVATED 699
7 ARTHRALGIA 658
8 NAUSEA 568
9 SYNOVITIS 544
See all common reactions for Interleukin-1 Receptor Antagonist [EPC]

Drugs of the Interleukin-1 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 264 0.9199
1 INFILTRATION ANAESTHESIA 20 0.7143
2 HUMAN ANTI-HUMAN ANTIBODY TEST 13 0.6190
3 BODY HEIGHT BELOW NORMAL 276 0.4678
4 CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME 7 0.4667
5 T-CELL DEPLETION 4 0.2500
6 INTESTINAL SEPSIS 32 0.2462
7 ANKLE ARTHROPLASTY 34 0.2282
8 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 7 0.2121
9 JUVENILE IDIOPATHIC ARTHRITIS 271 0.1967
See all enriched reactions for Interleukin-1 Receptor Antagonist [EPC]